BRAINSTORM CELL THERAPEUTICS INC.

Profile

Company Names

BRAINSTORM CELL THERAPEUTICS INC.

Addresses

1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY 10019

1745 BROADWAY, 17TH FLOOR, NEW YORK, NY 10019

3 UNIVERSITY DRIVE PLAZA, SUITE 320, HACKENSACK, NJ 07601

605 THIRD AVENUE, 34TH FLOOR, NEW YORK, NY 10158

Phone Numbers

201-488-0460
212-488-0460
646-666-3188

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$12,339,599.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2019-08-02 
$0.00 
INDEFINITE 
INDEFINITE 
 
5
2018-06-06 
$0.00 
INDEFINITE 
INDEFINITE 
 
4
2015-01-08 
$0.00 
INDEFINITE 
INDEFINITE 
 
3
2014-06-19 
$10,500,000.00 
$10,500,000.00 
$0.00 
Equity 
2
2014-04-25 
$1,632,689.00 
$2,470,590.00 
$837,901.00 
Equity 
1
2012-07-19 
$206,910.00 
$206,910.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DR. JUNE 
 
ALMENOFF 
DIRECTOR
ARTURO 
 
ARAYA 
EXECUTIVE OFFICER, DIRECTOR
DR. IRIT 
 
ARBEL 
DIRECTOR
ANTHONY 
 
FIORINO 
EXECUTIVE OFFICER
MORDECHAI 
 
FRIEDMAN 
DIRECTOR
ADRIAN 
 
HAREL 
EXECUTIVE OFFICER
ABRAHAM 
 
ISRAELI 
DIRECTOR
RALPH 
 
KERN 
EXECUTIVE OFFICER
CHAIM 
 
LEBOVITS 
EXECUTIVE OFFICER
ALON 
 
PINKAS 
DIRECTOR
DR. ANTHONY 
 
POLVERINO 
DIRECTOR
EYAL 
 
RUBIN 
EXECUTIVE OFFICER
LIAT 
 
SOSSOVER 
EXECUTIVE OFFICER
MALCOLM 
 
TAUB 
DIRECTOR
MALCOLM 
S. 
TAUB 
DIRECTOR
URI 
 
YABLONKA 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2019-08-02 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2018-06-06 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2015-01-08 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-06-19 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-04-25 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2012-07-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
MAXIM GROUP LLC
MAXIM PARTNERS LLC
MAXIM GROUP LLC
MAXIM GROUP LLC